Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis

Pediatric Blood and Cancer

Volumn 53, Issue 3, 2009, Pages 488-490

  RamaChandran, Shanti ^a   Ariffin, Hany ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Etoposide; Haemophagocytic lymphohistiocytosis; Secondary AML

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOSPORIN; ETOPOSIDE; METHOTREXATE; STEROID;

ABDOMINAL DISTENSION; ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CHILD; DRUG DOSE REGIMEN; DRUG EXPOSURE; FEVER; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; HYPOFIBRINOGENEMIA; IMMUNOPHENOTYPING; INFANT; JAUNDICE; LEUKOPENIA; LIVER DYSFUNCTION; NEUTROPENIA; PANCYTOPENIA; PHYSICAL EXAMINATION; PLEOCYTOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REMISSION; THROMBOCYTOPENIA; TREATMENT DURATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHILD, PRESCHOOL; ETOPOSIDE; FEMALE; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; NEOPLASMS, SECOND PRIMARY;

EID: 67651236952     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22063     Document Type: Article

References (21)

1. Ariffin H, Lum SH, Cheok SA, et al. Haemophagocytic lymphohistiocytosis in Malaysian children. J Paediatr Child Health 2005;41:136-139.
2. Ambruso DR, Hays T, Zwartjes WJ, et al. Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP-16-213. Cancer 1980;45:2516-2520. (Pubitemid 10105303)
3. Blanche S, Caniglia M, Girault D, et al. Treatment of hemophagocytic lymphohistiocytosis with chemotherapy and bone marrow transplantation: A single centre study of 22 cases. Blood 1991;78:51-54.
4. Bolme P, Henter J-I, Winiarski J, et al. Allogeneic bone marrow transplantation in hemophagocytic lymphohistiocytosis in Sweden. Bone Marrow Transplant 1995;15:331-335.
5. Green DM, Zevon MA, Reese PA, et al. Second malignant tumors following treatment during childhood and adolescence for cancer. Med Pediatr Oncol 1994;22:1-10. (Pubitemid 23361821)
6. Hawkins MM, Wilson LM, Stovall MA, et al. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. Br Med J 1992;304:951-958.
7. Boivin JF. Second cancers and other late side effects of cancer treatment. Cancer 1990;65:770-775. (Pubitemid 20067260)
8. Pui CH, Ribeiro RC, Hancock ML, et al. Acute myeloid leukaemia in children treated with epipodophyllotoxins for acute lymphoblastic leukaemia. N Engl J Med 1991;325:1682-1687.
9. Pedersen-Bjergaard J, Larsen SO. Incidence of acute nonlymphocytic leukaemia, preleukaemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease. N Engl J Med 1982;307:965-971. (Pubitemid 12018953)
10. Hoyle CF, De Bastos M, Wheatley K, et al. AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: Results from the MRC's 9th AML trial. Br J Haematol 1989;72:45-53. (Pubitemid 19133767)
11. Henter J-I, Elinder G, Öst A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 1991;18:29-33.
12. Pedersen-Bjergaard J. Insights into leukemogenesis from therapy-related leukemia. N Engl J Med 2005;352:1591-1594.
13. Leung W, Sandlund JT, Hudson MM, et al. Second malignancy after treatment of childhood non-Hodgkin lymphoma. Cancer 2001;92:1959-1966. (Pubitemid 32952517)
14. Shearer P, Kapoor G, Beckwith JB, et al. Secondary acute myelogenous leukaemia in patients previously treated for childhood renal tumors: A report from National Wilms Tumor Study Group. J Pediatr Hematol Oncol 2001;23:109-111. (Pubitemid 32162672)
15. Haupt R, Fears TR, Rosso P, et al. Increased risk of secondary leukaemia after single agent treatment with etoposide for Langerhans cell histiocytosis. Pediatr Hematol Oncol 1994;11:499-507. (Pubitemid 24280832)
16. Kitazawa J, Ito E, Arai K, et al. Secondary acute myeloid leukaemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis. Med Pediatr Oncol 2001;37:153-154. (Pubitemid 32738082)
17. Smith M, Rubenstein L, Anderson J, et al. Secondary leukaemia or myelodysplastic syndrome after treatment with epipodophyllotoxin. J Clin Oncol 1999; 569-577. (Pubitemid 29075244)
18. Pui C-H. Epipodophyllotoxin-related acute myeloid leukaemia. Lancet 1991;338:1468.
19. Le Deley M-C, Leblanc T, Shamsaldin A, et al. Risk of secondary leukaemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: A case control study by the Societe Francaise d' Oncologie Pediatrique. J Clin Oncol 2003;21:1074-1081. (Pubitemid 46594136)
20. Stine KC, Saylors RI, Sawyer JR, et al. Secondary acute myeloid leukaemia following safe exposure to etoposide. J Clin Oncol 1997;15:1583-1586. (Pubitemid 27167396)
21. Anderson JE, Gooley TA, Schoch G, et al. Stem cell transplantation for secondary acute myeloid leukaemia: Evaluation of transplantation as initial therapy or following induction chemotherapy. Blood 1997;89:2578-2585. (Pubitemid 27143308)